CNCR Summary


The Loncar Cancer Immunotherapy ETF

ETF Information as of 03/16/2018

ETF Summary

ETF Info
Primary Exchange NASDAQ
Ticker CNCR
Index Symbol LCINDX
Index Provider Loncar Investments, LLC
Index Calculator Indxx, LLC
CUSIP 26922A826
Net Assets $64,265,021.63
Shares Outstanding 2,100,000
Number of Holdings 31
Weighting Equal-Weighted
Rebalanced Semi-Annually
Reconstituted Semi-Annually
Fund Inception Date 10/13/15
Management Fee 0.79%
Gross Expense Ratio 0.79%
Net Asset Value $30.60
Daily Change
Market Price
Closing Price $30.65
Daily Change $-0.11
Premium Discount
NAV $30.60
Mid-Point $30.65
Premium/Discount 0.14%
Ex-Date 12/28/2017
Record Date 12/29/2017
Payable Date 1/2/2018
Amount $0.35019938
Short-Term Capital Gains N/A

The fund's investment in securities that are less actively traded or over time experience decreased trading volume may affect adversely the fund's ability to make dividend distributions.

Download Investor Materials